Results 191 to 200 of about 7,770 (204)

Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

ESMO Open, 2016
Alexandru Eniu, Solange Peters, Josep Tabernero   +2 more
exaly  

Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice

Pharmacological Research, 2017
Francesco Rossi, Concetta Rafaniello, Annalisa Capuano   +2 more
exaly  

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

ESMO Open, 2019
Josep Tabernero, Fatima Cardoso
exaly  

Comparing Originator Biologics and Biosimilars: A Review of the Relevant Issues

Clinical Therapeutics, 2017
Corrado Blandizzi, Pier Luigi Meroni, Giovanni Lapadula   +2 more
exaly  

The nocebo effect: a clinical challenge in the era of biosimilars

Expert Review of Clinical Immunology, 2018
Silvio Danese, Lieven Pouillon, Beatrice Demore   +2 more
exaly  

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars

Pharmaceutics, 2018
Simona Codruţa Hegheș, Cristina Adela Iuga, Maria Iacobescu   +2 more
exaly  

Changes in inflammatory bowel disease patients’ perspectives on biosimilars: A follow‐up survey

United European Gastroenterology Journal, 2019
Silvio Danese, Laurent Peyrin-Biroulet
exaly  

Comparative Immunogenicity Assessment of Biosimilars

Future Oncology, 2019
Georgios Bakalos
exaly  

Biosimilars: How Similar are They?

The International Journal of Artificial Organs, 2005
openaire   +3 more sources

Biosimilars: Hope and concern

Journal of Oncology Pharmacy Practice, 2016
exaly